Recipient Evalation Year 3 Effectiveness Brief

National Evaluation of the DP18-1815 Cooperative Agreement Program: Category B, Cardiovascular Disease Prevention and Management

Att 6c. Cat B Rec Eval Annual Report Temp Y3

OMB: 0920-1311

Document [docx]
Download: docx | pdf

Form Approved

OMB No. 0920-xxxx

Exp. Date XX/XX/20XX



Shape2

DRAFT

[INSERT NOFO HERE]

Recipient Evaluation Deliverable Guidance & TA Tool

Shape3

DRAFT

Year 3-Effectiveness Brief


Note:30333; ATTN: PRA (0920-20HP) hours per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 8 Public reporting burden of this collection of information is estimated to average


Each year [INSERT NOFO HERE] recipients are required to submit an evaluation deliverable to report findings from the previous year’s evaluation efforts that reflects the specific core area outlined in the [INSERT NOFO HERE] Evaluation and Performance Measurement Plan (EPMP) Guidance. In Year 3, recipients are required to submit an Effectiveness Brief that describes the evaluation core area of Effectiveness. This brief provides recipients the opportunity to assess the program’s early outcomes (e.g., health behavior changes, policy changes, or improvements in health outcomes) and reach and provides an opportunity to re-assess the facilitators and barriers to program implementation. These assessments may provide the information needed to make programmatic adjustments necessary to ensure intended health outcomes are achieved.

This report should include an Effectiveness Brief Overview and a Strategy Specific Effectiveness Brief for each strategy evaluated. This reporting deliverable is due to CDC on [INSERT DUE DATE HERE]. Specific instructions for submission will be provided prior to that date. The reporting deliverable will require up to 8 hours to complete.



The Effectiveness Brief Overview (1 page) should include:

(Table 1 in TA Tool)

  • Overview of the program: Provide a brief statement of the public health problem or burden that your program aims to address. This section should also describe the strategies that your program has selected to evaluate, the intended outcomes of these strategies, and the priority population targeted.

  • Purpose of the evaluation: Describe the general purpose of the evaluation in Year 3.

  • Use of Year 1 and 2 Evaluation Findings: Describe how you used the findings from year 1 and 2 to guide the evaluation questions and methods for the year 3 program effectiveness evaluation.

  • Overarching evaluation questions: Provide the overarching Effectiveness Core Area evaluation questions you assessed in Year 3.

  • Methods: Describe the evaluation design, data collection methods, and data analysis methods for the core area of efficiency evaluated in Year 3.

The Strategy Specific Effectiveness Brief (1 page for each strategy evaluated) includes:

(Table 2 in TA Tool)

  • Progress on early outcomes: Describe the early outcomes achieved and how the implemented activities have led to these changes in Year 3 for the selected strategy. These outcomes may include health behavior changes, policy changes, or improvements in health outcomes. Please also specify any progress specific to the priority population.

  • Data Table or Figure: Include a data table or figure that demonstrates the findings from your analysis.

  • Reach of intervention: Describe the reach of the interventions for the selected strategy from baseline to Year 3.

  • Facilitators and barriers: Describe the facilitators and barriers of the program’s implementation and how these affected the early outcomes of the strategy.

  • Benchmarks tracked in Year 4: Describe what indicators related to program sustainability and data driven decision making of the selected strategy will be tracked in Year 4.



Note: The Effectiveness Brief is designed to provide a high-level of evaluation methods and findings. Recipients may include appendices with supplemental evaluation findings and data collection tools.



Table 1. Effectiveness Brief Overview (TA Tool)

Overview of the Program

Purpose of evaluation

Please provide a brief statement of the problem or burden for your program, describe the strategies you’ve selected to evaluate, the intended outcomes, and priority population served (be sure to include updated prevalence and baseline data and preliminary CVD findings). Please also describe the history, background and context of your organization and the program as it relates to your Year 3 findings.



Describe the general purpose of the evaluation in Year 3. Information can be taken from the Year 3 evaluation plan.






Use of Year 1 and 2 Evaluation Findings

Describe how you used the findings from year 1 and 2 to guide the evaluation questions and methods for the year 3 program effectiveness evaluation.






Overarching Evaluation Questions

Provide the overarching Effectiveness Core Area evaluation questions you assessed in Year 3. Information can be taken from the multi-year and Year 3 evaluation plan.

Strategy 1.

Strategy 2.

Strategy 3.

Methods

Describe the evaluation design, data collection methods, and data analysis methods for the core area of efficiency evaluated in Year 3. Information can be taken from the Year 3 evaluation plan.

Evaluation Design

Evaluation Data Collection Methods and Analysis

Strategy 1.


Strategy 2.


Strategy 3.








Table 2. Strategy Specific Effectiveness Brief

Strategy 1:



Finding

Description

Progress on Early Outcomes


Describe the early outcomes achieved and how the implemented activities have led to these changes in Year 3 for the selected strategy. These outcomes may include health behavior changes, policy changes, or improvements in health outcomes. Please also specify any progress specific to the priority population.

Data Table or Figure

Include a data table or figure that demonstrates the findings from your analysis.




























Reach of Intervention

Describe the reach of the interventions for the selected strategy from baseline to Year 3.

Facilitators and Barriers

Describe the facilitators and barriers of the program’s implementation and how these affected the early outcomes of the strategy.

Benchmarks Tracked in Year 4 (Process or Outcome Measures)

Describe what indicators related to program sustainability and data driven decision making of the selected strategy will be tracked in Year 4.





















Strategy 2:



Finding

Description

Progress on Early Outcomes


Describe the early outcomes achieved and how the implemented activities have led to these changes in Year 3 for the selected strategy. These outcomes may include health behavior changes, policy changes, or improvements in health outcomes. Please also specify any progress specific to the priority population.

Data Table or Figure

Include a data table or figure that demonstrates the findings from your analysis.




























Reach of Intervention

Describe the reach of the interventions for the selected strategy from baseline to Year 3.

Facilitators and Barriers

Describe the facilitators and barriers of the program’s implementation and how these affected the early outcomes of the strategy.

Benchmarks Tracked in Year 4 (Process or Outcome Measures)

Describe what indicators related to program sustainability and data driven decision making of the selected strategy will be tracked in Year 4.





















Strategy 3:



Finding

Description

Progress on Early Outcomes


Describe the early outcomes achieved and how the implemented activities have led to these changes in Year 3 for the selected strategy. These outcomes may include health behavior changes, policy changes, or improvements in health outcomes. Please also specify any progress specific to the priority population.

Data Table or Figure

Include a data table or figure that demonstrates the findings from your analysis.




























Reach of Intervention

Describe the reach of the interventions for the selected strategy from baseline to Year 3.

Facilitators and Barriers

Describe the facilitators and barriers of the program’s implementation and how these affected the early outcomes of the strategy.

Benchmarks Tracked in Year 4 (Process or Outcome Measures)

Describe what indicators related to program sustainability and data driven decision making of the selected strategy will be tracked in Year 4.



File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorDavis, Rachel (CDC/ONDIEH/NCCDPHP)
File Modified0000-00-00
File Created2021-12-20

© 2024 OMB.report | Privacy Policy